Effect of nebulized Salbutamol versus Epinephrine in treatment of transient tachypnea of neonates
Phase 3
Recruiting
- Conditions
- Transient Tachypnea of Neonates.Transient tachypnea of newbornP22.1
- Registration Number
- IRCT20221028056324N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Transient tachypnea of neonates
Neonatal intensive care unit
Exclusion Criteria
First minute apgar below 4
Respiratory distress syndrome caused by surfactant deficiency
Congenital anomalies
Syndromes of chromosomal disorders
Congenital heart diseases
Premature neonatal sepsis
Meconium aspiration
Infants with metabolic disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Respiratory rate. Timepoint: Half an hour, one hour and four hours after nebulizer administration. Method of measurement: Physical examination.;Heart rate. Timepoint: Half an hour, one hour and four hours after nebulizer administration. Method of measurement: Noninvasive pulsoxymetry.;Oxygen saturation. Timepoint: Half an hour, one hour and four hours after nebulizer administration. Method of measurement: Noninvasive pulsoxymetry.
- Secondary Outcome Measures
Name Time Method